CircRNAs: biogenesis, functions, and role in drug-resistant Tumours

Mol Cancer. 2020 Aug 5;19(1):119. doi: 10.1186/s12943-020-01231-4.

Abstract

Targeted treatment, which can specifically kill tumour cells without affecting normal cells, is a new approach for tumour therapy. However, tumour cells tend to acquire resistance to targeted drugs during treatment. Circular RNAs (circRNAs) are single-stranded RNA molecules with unique structures and important functions. With the development of RNA sequencing technology, circRNAs have been found to be widespread in tumour-resistant cells and to play important regulatory roles. In this review, we present the latest advances in circRNA research and summarize the various mechanisms underlying their regulation. Moreover, we review the role of circRNAs in the chemotherapeutic resistance of tumours and explore the clinical value of circRNA regulation in treating tumour resistance.

Keywords: Circular RNAs (CircRNAs); Functions; Self-circularize; Targeted treatment; Tumor resistance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor
  • Drug Resistance, Neoplasm / genetics*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Organ Specificity
  • RNA Interference
  • RNA Transport
  • RNA, Circular*
  • Transcription, Genetic

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • RNA, Circular